{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:21:30Z","timestamp":1793276490268,"version":"4.5.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gastric cancer remains a leading cause of cancer-related morbidity and mortality worldwide. The genetic factors contributing to gastric cancer progression and resistance to therapies, particularly radiotherapy, are not fully understood. TP53, ATM, RAD51, and BAX are genes involved in DNA repair, apoptosis, and response to stress. The aim of this study was to investigate the expression patterns of these genes in gastric cancer, their potential role in radiotherapy resistance, and their diagnostic value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>Gene expression levels of TP53, ATM, RAD51, and BAX were assessed using RT-qPCR across 9 gastric cancer cell lines and 6 normal control cell lines. Additionally, protein expression was confirmed via IHC and TCGA dataset analysis. Methylation levels of these genes were evaluated in gastric cancer tissues using the GSCA database. Mutational analysis was conducted using cBioPortal, and survival analysis was performed using Kaplan-Meier and meta-analysis. The radiotherapy resistance study was carried out by knocking down TP53, RAD51, and BAX in AGS and MKN-45 gastric cancer cell lines, followed by expression analysis, colony formation, and wound healing assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression of TP53, RAD51, and BAX was significantly upregulated, while ATM was downregulated in gastric cancer cell lines compared to normal controls. All four genes demonstrated good discriminatory power (AUC\u2009=\u20091) in distinguishing gastric cancer from normal samples. Methylation analysis revealed significant hypomethylation of TP53, RAD51, and BAX, and hypermethylation of ATM in gastric cancer tissues. Mutational analysis showed that TP53 was altered in 88% of gastric cancer samples, while ATM, RAD51, and BAX exhibited lower mutation rates. Survival analysis suggested that elevated expression of TP53, RAD51, and BAX may be linked to poorer survival outcomes, while reduced ATM expression appeared to associate with decreased overall survival. However, these associations require further validation through additional studies. Knockdown of TP53, RAD51, and BAX in AGS and MKN-45 cells resulted in significantly reduced cell proliferation and slower wound healing, highlighting their role in radiotherapy resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The TP53, RAD51, and BAX genes are significantly involved in gastric cancer progression and resistance to radiotherapy. Their expression and mutation status provide valuable diagnostic and prognostic information.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00496-3","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T06:31:17Z","timestamp":1752301877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["RETRACTED ARTICLE: In silico and in vitro assessment of TP53, ATM, RAD51, and BAX genes in gastric cancer and their contribution to radiotherapy resistance"],"prefix":"10.1186","volume":"162","author":[{"given":"Junwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengtao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"issue":"12","key":"496_CR1","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1158\/1055-9965.EPI-24-0835","volume":"33","author":"A Riquelme","year":"2024","unstructured":"Riquelme A, Abnet CC. The burden of gastric Cancer in Northern central America. Cancer Epidemiol Biomarkers Prev. 2024;33(12):1550\u20132.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"496_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00432-024-05880-6","volume":"150","author":"N Patwa","year":"2024","unstructured":"Patwa N, Chauhan R, Chauhan A, Kumar M, Ramniwas S, Mathkor DM, et al. Garcinol in Gastrointestinal cancer prevention: recent advances and future prospects. J Cancer Res Clin Oncol. 2024;150(7):370.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"496_CR3","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1186\/s12889-024-19104-6","volume":"24","author":"J-L Lin","year":"2024","unstructured":"Lin J-L, Lin J-X, Lin G-T, Huang C-M, Zheng C-H, Xie J-W, et al. Global incidence and mortality trends of gastric cancer and predicted mortality of gastric cancer by 2035. BMC Public Health. 2024;24(1):1763.","journal-title":"BMC Public Health"},{"key":"496_CR4","doi-asserted-by":"crossref","first-page":"155460","DOI":"10.1016\/j.prp.2024.155460","volume":"260","author":"Z Guo","year":"2024","unstructured":"Guo Z, Guan K, Bao M, He B, Lu J. LINC-PINT plays an anti-tumor role in nasopharyngeal carcinoma by binding to XRCC6 and affecting its function. Pathology-Research Pract. 2024;260:155460.","journal-title":"Pathology-Research Pract"},{"key":"496_CR5","doi-asserted-by":"crossref","first-page":"1432869","DOI":"10.3389\/fonc.2024.1432869","volume":"14","author":"S Chen","year":"2024","unstructured":"Chen S, Long S, Liu Y, Wang S, Hu Q, Fu L, et al. Evaluation of a three-gene methylation model for correlating lymph node metastasis in postoperative early gastric cancer adjacent samples. Front Oncol. 2024;14:1432869.","journal-title":"Front Oncol"},{"issue":"9","key":"496_CR6","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3390\/cancers16091708","volume":"16","author":"C Burz","year":"2024","unstructured":"Burz C, Pop V, Silaghi C, Lupan I, Samasca G. Prognosis and treatment of gastric cancer: a 2024 update. Cancers. 2024;16(9):1708.","journal-title":"Cancers"},{"issue":"6","key":"496_CR7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/pin.13427","volume":"74","author":"T Kuwata","year":"2024","unstructured":"Kuwata T. Molecular classification and intratumoral heterogeneity of gastric adenocarcinoma. Pathol Int. 2024;74(6):301\u201316.","journal-title":"Pathol Int"},{"issue":"10","key":"496_CR8","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.7150\/jca.95311","volume":"15","author":"Y Huang","year":"2024","unstructured":"Huang Y, Shao Y, Yu X, Chen C, Guo J, Ye G. Global progress and future prospects of early gastric cancer screening. J Cancer. 2024;15(10):3045.","journal-title":"J Cancer"},{"key":"496_CR9","doi-asserted-by":"crossref","first-page":"119513","DOI":"10.1016\/j.ijpharm.2020.119513","volume":"585","author":"Y Nie","year":"2020","unstructured":"Nie Y, Li D, Peng Y, Wang S, Hu S, Liu M, et al. Metal organic framework coated MnO2 nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer. Int J Pharm. 2020;585:119513.","journal-title":"Int J Pharm"},{"issue":"1","key":"496_CR10","doi-asserted-by":"publisher","first-page":"25331","DOI":"10.1038\/s41598-024-76798-9","volume":"14","author":"Z Cao","year":"2024","unstructured":"Cao Z, Zhu J, Wang Z, Peng Y, Zeng L. Comprehensive pan-cancer analysis reveals ENC1 as a promising prognostic biomarker for tumor microenvironment and therapeutic responses. Sci Rep. 2024;14(1):25331.","journal-title":"Sci Rep"},{"key":"496_CR11","doi-asserted-by":"crossref","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024.","DOI":"10.20944\/preprints202401.1989.v1"},{"issue":"3","key":"496_CR12","first-page":"105","volume":"10","author":"RM Joshi","year":"2024","unstructured":"Joshi RM, Telang B, Soni G, Khalife A. Overview of perspectives on cancer, newer therapies, and future directions. Oncol Translational Med. 2024;10(3):105\u20139.","journal-title":"Oncol Translational Med"},{"issue":"3","key":"496_CR13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/toxres\/tfad024","volume":"12","author":"W Peng","year":"2023","unstructured":"Peng W, Chen L, Liu J. Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1\/CLDN4 axis. Toxicol Res. 2023;12(3):392\u20139.","journal-title":"Toxicol Res"},{"issue":"1","key":"496_CR14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cac2.12516","volume":"44","author":"FH Wang","year":"2024","unstructured":"Wang FH, Zhang XT, Tang L, Wu Q, Cai MY, Li YF, et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun. 2024;44(1):127\u201372.","journal-title":"Cancer Commun"},{"issue":"4","key":"496_CR15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1568009623666230817102104","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang Z, Tang Z, Fu Y, Wang L. mirna-383-5p functions as an Anti-oncogene in glioma through the akt\/mtor signaling pathway by targeting VEGFA. Curr Cancer Drug Targets. 2024;24(4):463\u201375.","journal-title":"Curr Cancer Drug Targets"},{"issue":"16","key":"496_CR16","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.7150\/jca.98723","volume":"15","author":"L Liang","year":"2024","unstructured":"Liang L, Liang X, Yu X, Xiang W. Bioinformatic analyses and integrated machine learning to predict prognosis and therapeutic response based on E3 ligase-related genes in colon cancer. J Cancer. 2024;15(16):5376.","journal-title":"J Cancer"},{"issue":"3","key":"496_CR17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mco2.55","volume":"2","author":"YP Liu","year":"2021","unstructured":"Liu YP, Zheng CC, Huang YN, He ML, Xu WW, Li B. Molecular mechanisms of chemo-and radiotherapy resistance and the potential implications for cancer treatment. MedComm. 2021;2(3):315\u201340.","journal-title":"MedComm"},{"issue":"191","key":"496_CR18","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.24976\/Discov.Med.202436191.222","volume":"36","author":"C Li","year":"2024","unstructured":"Li C, Chu Y, Dai H, Xian Q, Zhu W. KDM4C and GFPT1: potential therapeutic targets for gastric Cancer. Discov Med. 2024;36(191):2408\u201320.","journal-title":"Discov Med"},{"issue":"1160","key":"496_CR19","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/bjr\/tqae100","volume":"97","author":"K Passelli","year":"2024","unstructured":"Passelli K, Rep\u00e1raz D, Kinj R, Herrera FG. Strategies for overcoming tumour resistance to immunotherapy: Harnessing the power of radiation therapy. Br J Radiol. 2024;97(1160):1378\u201390.","journal-title":"Br J Radiol"},{"issue":"1","key":"496_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/biomedicines12010183","volume":"12","author":"M Eslami","year":"2024","unstructured":"Eslami M, Memarsadeghi O, Davarpanah A, Arti A, Nayernia K, Behnam B. Overcoming chemotherapy resistance in metastatic cancer: a comprehensive review. Biomedicines. 2024;12(1):183.","journal-title":"Biomedicines"},{"key":"496_CR21","doi-asserted-by":"crossref","unstructured":"Batool A, Rashid W, Fatima K, Khan SU. Mechanisms of Cancer resistance to various therapies. Drug resistance in cancer: mechanisms and strategies. Springer; 2024. pp. 31\u201375.","DOI":"10.1007\/978-981-97-1666-1_2"},{"key":"496_CR22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/bs.ircmb.2023.07.008","volume":"383","author":"E Arechaga-Ocampo","year":"2024","unstructured":"Arechaga-Ocampo E. Epigenetics as a determinant of radiation response in cancer. Int Rev Cell Mol Biology. 2024;383:145\u201390.","journal-title":"Int Rev Cell Mol Biology"},{"issue":"1","key":"496_CR23","doi-asserted-by":"crossref","first-page":"e13409","DOI":"10.1111\/imr.13409","volume":"329","author":"S Saini","year":"2025","unstructured":"Saini S, Gurung P. A comprehensive review of sensors of radiation-induced damage, radiation\u2010induced proximal events, and cell death. Immunol Rev. 2025;329(1):e13409.","journal-title":"Immunol Rev"},{"issue":"9","key":"496_CR24","first-page":"102714","volume":"31","author":"L-X Liang","year":"2025","unstructured":"Liang L-X, Liang X, Zeng Y, Wang F, Yu X-K. Establishment and validation of a nomogram for predicting esophagogastric variceal bleeding in patients with liver cirrhosis. World J Gastroenterol. 2025;31(9):102714.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"496_CR25","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1038\/s41467-025-58921-0","volume":"16","author":"G Zhang","year":"2025","unstructured":"Zhang G, Song C, Yin M, Liu L, Zhang Y, Li Y, et al. TRAPT: a multi-stage fused deep learning framework for predicting transcriptional regulators based on large-scale epigenomic data. Nat Commun. 2025;16(1):3611.","journal-title":"Nat Commun"},{"key":"496_CR26","doi-asserted-by":"crossref","unstructured":"Feroz M, Jan A, Yasin J, Mir MA. p53 control of cell cycle dynamics in breast cancer: maintaining a balance between arrest and proliferation. p53 in breast Cancer. CRC; 2025. pp. 127\u201345.","DOI":"10.1201\/9781003520771-8"},{"key":"496_CR27","doi-asserted-by":"crossref","unstructured":"Ahmed MM, Malachowska B, Guha C. Radiation-Induced tissue regeneration: pathways, mechanisms, and therapeutic potential. Hematology\/Oncology Clinics; 2025.","DOI":"10.1016\/j.hoc.2024.12.003"},{"issue":"2","key":"496_CR28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1667\/RADE-20-00009","volume":"194","author":"NH Patel","year":"2020","unstructured":"Patel NH, Sohal SS, Manjili MH, Harrell JC, Gewirtz DA. The roles of autophagy and senescence in the tumor cell response to radiation. Radiat Res. 2020;194(2):103\u201315.","journal-title":"Radiat Res"},{"key":"496_CR29","doi-asserted-by":"crossref","first-page":"114504","DOI":"10.1016\/j.addr.2022.114504","volume":"189","author":"R Rimal","year":"2022","unstructured":"Rimal R, Desai P, Daware R, Hosseinnejad A, Prakash J, Lammers T, et al. Cancer-associated fibroblasts: origin, function, imaging, and therapeutic targeting. Adv Drug Deliv Rev. 2022;189:114504.","journal-title":"Adv Drug Deliv Rev"},{"key":"496_CR30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12964-025-02138-7","volume":"23","author":"L Zheng","year":"2025","unstructured":"Zheng L, Cai W, Ke Y, Hu X, Yang C, Zhang R, et al. Cancer\u2013associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapy. Cell Communication Signaling: CCS. 2025;23:147.","journal-title":"Cell Communication Signaling: CCS"},{"issue":"1","key":"496_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-024-01259-9","volume":"32","author":"A Janic","year":"2025","unstructured":"Janic A, Abad E, Amelio I. Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control? Cell Death Differ. 2025;32(1):1\u20138.","journal-title":"Cell Death Differ"},{"issue":"5","key":"496_CR32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3390\/genes15050577","volume":"15","author":"R Khan","year":"2024","unstructured":"Khan R, Pari B, Puszynski K. Comprehensive bioinformatic investigation of TP53 dysregulation in diverse cancer landscapes. Genes. 2024;15(5):577.","journal-title":"Genes"},{"issue":"1","key":"496_CR33","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1038\/s41467-024-48307-z","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang H, Li Q, Chen X, Weng M, Huang Y, Chen Q, et al. Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer. Nat Commun. 2024;15(1):4296.","journal-title":"Nat Commun"},{"issue":"4","key":"496_CR34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/radiation4040023","volume":"4","author":"T Al-Arafat","year":"2024","unstructured":"Al-Arafat T-, Mao A, Katsube T, Wang B. Exploring the role of p53 in radiosensitivity: A key player in Cancer therapy. Radiation. 2024;4(4):309\u201324.","journal-title":"Radiation"},{"issue":"17","key":"496_CR35","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.3390\/cancers16173069","volume":"16","author":"C Wang","year":"2024","unstructured":"Wang C, Tan JYM, Chitkara N, Bhatt S. TP53 mutation-mediated immune evasion in cancer: mechanisms and therapeutic implications. Cancers. 2024;16(17):3069.","journal-title":"Cancers"},{"key":"496_CR36","doi-asserted-by":"crossref","first-page":"155447","DOI":"10.1016\/j.prp.2024.155447","volume":"260","author":"V Varadhan","year":"2024","unstructured":"Varadhan V, Manikandan MS, Nagarajan A, Palaniyandi T, Ravi M, Sankareswaran SK, et al. Ataxia-Telangiectasia mutated (ATM) gene signaling pathways in human cancers and their therapeutic implications. Pathology-Research Pract. 2024;260:155447.","journal-title":"Pathology-Research Pract"},{"key":"496_CR37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.procbio.2024.05.024","volume":"144","author":"A Rameshkumar","year":"2024","unstructured":"Rameshkumar A, ArunPrasanna V, Mahalakshmi V, Raja MR, Gopinath K. Recent advancement of analytical approaches for assessing Ataxia telangiectasia mutated kinase inhibitors in Ataxia telangiectasia: an overview. Process Biochem. 2024;144:142\u201359.","journal-title":"Process Biochem"},{"key":"496_CR38","doi-asserted-by":"crossref","unstructured":"Xie Y, Liu Y, Lin M, Li Z, Shen Z, Yin S et al. Targeting ATM enhances radiation sensitivity of colorectal cancer by potentiating radiation-induced cell death and antitumor immunity. J Adv Res. 2024.","DOI":"10.1016\/j.jare.2024.12.023"},{"issue":"3","key":"496_CR39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s13402-023-00906-6","volume":"47","author":"A Porrazzo","year":"2024","unstructured":"Porrazzo A, Cassandri M, D\u2019Alessandro A, Morciano P, Rota R, Marampon F, et al. DNA repair in tumor radioresistance: insights from fruit flies genetics. Cell Oncol. 2024;47(3):717\u201332.","journal-title":"Cell Oncol"},{"issue":"W1","key":"496_CR40","doi-asserted-by":"crossref","first-page":"W520","DOI":"10.1093\/nar\/gkad408","volume":"51","author":"F-C Qian","year":"2023","unstructured":"Qian F-C, Zhou L-W, Li Y-Y, Yu Z-M, Li L-D, Wang Y-Z, et al. SEanalysis 2.0: a comprehensive super-enhancer regulatory network analysis tool for human and mouse. Nucleic Acids Res. 2023;51(W1):W520\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"496_CR41","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/ptr.8157","volume":"38","author":"WW Iksen","year":"2024","unstructured":"Iksen WW, Hardianti B, Pongrakhananon V. Comprehensive review of Bcl-2 family proteins in cancer apoptosis: therapeutic strategies and promising updates of natural bioactive compounds and small molecules. Phytother Res. 2024;38(5):2249\u201375.","journal-title":"Phytother Res"},{"key":"496_CR42","doi-asserted-by":"crossref","first-page":"148795","DOI":"10.1016\/j.brainres.2024.148795","volume":"1829","author":"K Xu","year":"2024","unstructured":"Xu K, Liu Z, Pan S, Zhang N, Wu S, Yang G, et al. BMSCs attenuate radiation-induced brain injury induced hippocampal neuronal apoptosis through a PI3K\/Akt\/Bax\/Bcl-2 signaling pathway. Brain Res. 2024;1829:148795.","journal-title":"Brain Res"},{"issue":"1","key":"496_CR43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood-2003-04-1161","volume":"103","author":"T Stankovic","year":"2004","unstructured":"Stankovic T, Hubank M, Cronin D, Stewart GS, Fletcher D, Bignell CR, et al. Microarray analysis reveals that TP53-and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses. Blood. 2004;103(1):291\u2013300.","journal-title":"Blood"},{"issue":"10","key":"496_CR44","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s12276-022-00863-4","volume":"54","author":"Y Abuetabh","year":"2022","unstructured":"Abuetabh Y, Wu HH, Chai C, Al Yousef H, Persad S, Sergi CM, et al. DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities. Exp Mol Med. 2022;54(10):1658\u201369.","journal-title":"Exp Mol Med"},{"issue":"9","key":"496_CR45","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.stem.2024.06.007","volume":"31","author":"C Zhou","year":"2024","unstructured":"Zhou C, Kuang M, Tao Y, Wang J, Luo Y, Fu Y, et al. Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening. Cell Stem Cell. 2024;31(9):1359\u201375. e8.","journal-title":"Cell Stem Cell"},{"issue":"33","key":"496_CR46","doi-asserted-by":"crossref","first-page":"2308711","DOI":"10.1002\/advs.202308711","volume":"11","author":"F Chen","year":"2024","unstructured":"Chen F, Zhang K, Wang M, He Z, Yu B, Wang X, et al. VEGF-FGF signaling activates quiescent CD63\u2009+\u2009Liver stem cells to proliferate and differentiate. Adv Sci. 2024;11(33):2308711.","journal-title":"Adv Sci"},{"issue":"1","key":"496_CR47","doi-asserted-by":"publisher","first-page":"20002","DOI":"10.1038\/s41598-022-16744-9","volume":"12","author":"B Liu","year":"2022","unstructured":"Liu B, Du H, Zhang J, Jiang J, Zhang X, He F, et al. Developing a new sepsis screening tool based on lymphocyte count, international normalized ratio and procalcitonin (LIP score). Sci Rep. 2022;12(1):20002.","journal-title":"Sci Rep"},{"issue":"7","key":"496_CR48","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.stem.2024.04.021","volume":"31","author":"S Li","year":"2024","unstructured":"Li S, Ling S, Wang D, Wang X, Hao F, Yin L, et al. Modified lentiviral globin gene therapy for pediatric \u03b20\/\u03b20 transfusion-dependent \u03b2-thalassemia: A single-center, single-arm pilot trial. Cell Stem Cell. 2024;31(7):961\u201373. e8.","journal-title":"Cell Stem Cell"},{"key":"496_CR49","doi-asserted-by":"crossref","unstructured":"Khan M, Hameed Y. Discovery of novel six genes-based cervical cancer-associated biomarkers that are capable to break the heterogeneity barrier and applicable at the global level. J Cancer Res Ther. 2023.","DOI":"10.4103\/jcrt.jcrt_1588_21"},{"issue":"1","key":"496_CR50","doi-asserted-by":"crossref","first-page":"bbac558","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"C-J Liu","year":"2023","unstructured":"Liu C-J, Hu F-F, Xie G-Y, Miao Y-R, Li X-W, Zeng Y, et al. GSCA: an integrated platform for gene set cancer analysis at genomic, Pharmacogenomic and Immunogenomic levels. Brief Bioinform. 2023;24(1):bbac558.","journal-title":"Brief Bioinform"},{"issue":"1","key":"496_CR51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/pro.3307","volume":"27","author":"PJ Thul","year":"2018","unstructured":"Thul PJ, Lindskog C. The human protein atlas: a Spatial map of the human proteome. Protein Sci. 2018;27(1):233\u201344.","journal-title":"Protein Sci"},{"issue":"W1","key":"496_CR52","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"496_CR53","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"7","key":"496_CR54","doi-asserted-by":"crossref","first-page":"e27633","DOI":"10.2196\/27633","volume":"23","author":"A L\u00e1nczky","year":"2021","unstructured":"L\u00e1nczky A, Gy\u0151rffy B. Web-Based survival analysis tool tailored for medical research (KMplot): development and implementation. J Med Internet Res. 2021;23(7):e27633.","journal-title":"J Med Internet Res"},{"issue":"5","key":"496_CR55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12920-019-0514-7","volume":"12","author":"S-J Park","year":"2019","unstructured":"Park S-J, Yoon B-H, Kim S-K, Kim S-Y. GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genom. 2019;12(5):101.","journal-title":"BMC Med Genom"},{"issue":"20","key":"496_CR56","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200\u20132.","journal-title":"Bioinformatics"},{"key":"496_CR57","doi-asserted-by":"crossref","first-page":"1559396","DOI":"10.3389\/fimmu.2025.1559396","volume":"16","author":"L Chen","year":"2025","unstructured":"Chen L, He Y, Duan M, Yang T, Chen Y, Wang B, et al. Exploring NUP62\u2019s role in cancer progression, tumor immunity, and treatment response: insights from multi-omics analysis. Front Immunol. 2025;16:1559396.","journal-title":"Front Immunol"},{"issue":"8","key":"496_CR58","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/cancers17081379","volume":"17","author":"X Fan","year":"2025","unstructured":"Fan X, Brunetti TM, Jackson K, Roop DR. Single-Cell profiling reveals global immune responses during the progression of murine epidermal neoplasms. Cancers. 2025;17(8):1379.","journal-title":"Cancers"},{"key":"496_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1514-3","volume":"39","author":"K Yuan","year":"2020","unstructured":"Yuan K, Ye J, Liu Z, Ren Y, He W, Xu J, et al. Complement C3 overexpression activates JAK2\/STAT3 pathway and correlates with gastric cancer progression. J Experimental Clin Cancer Res. 2020;39:1\u201315.","journal-title":"J Experimental Clin Cancer Res"},{"key":"496_CR60","doi-asserted-by":"crossref","unstructured":"Laga T, Van Rompuy A, Busschaert P, Marquina G, Loverix L, Olbrecht S et al. Single-cell profiling in ovarian germ cell and sex cord-stromal tumours. Br J Cancer. 2025:1\u201314.","DOI":"10.1038\/s41416-025-03012-6"},{"key":"496_CR61","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.csbj.2022.04.037","volume":"20","author":"R Zhou","year":"2022","unstructured":"Zhou R, Wen Z, Liao Y, Wu J, Xi S, Zeng D, et al. Evaluation of stromal cell infiltration in the tumor microenvironment enable prediction of treatment sensitivity and prognosis in colon cancer. Comput Struct Biotechnol J. 2022;20:2153\u201368.","journal-title":"Comput Struct Biotechnol J"},{"issue":"W1","key":"496_CR62","doi-asserted-by":"crossref","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","volume":"48","author":"L Chang","year":"2020","unstructured":"Chang L, Zhou G, Soufan O, Xia J. MiRNet 2.0: network-based visual analytics for MiRNA functional analysis and systems biology. Nucleic Acids Res. 2020;48(W1):W244\u201351.","journal-title":"Nucleic Acids Res"},{"key":"496_CR63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"key":"496_CR64","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The genemania prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214\u201320. Web Server issue).","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"496_CR65","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis","year":"2003","unstructured":"Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4(5):P3.","journal-title":"Genome Biol"},{"issue":"9","key":"496_CR66","first-page":"3536","volume":"6","author":"S Angele","year":"2000","unstructured":"Angele S, Treilleux I, Taniere P, Martel-Planche G, Vuillaume Ml, Bailly C, et al. Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas. Clin Cancer Res. 2000;6(9):3536\u201344.","journal-title":"Clin Cancer Res"},{"key":"496_CR67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF01008033","volume":"430","author":"V Manetto","year":"1997","unstructured":"Manetto V, Lorenzini R, Cordon-Cardo C, Krajewski S, Rosai J, Reed JC, et al. Bcl-2 and Bax expression in thyroid tumours an immunohistochemical and Western blot analysis. Virchows Arch. 1997;430:125\u201330.","journal-title":"Virchows Arch"},{"issue":"13","key":"496_CR68","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.3390\/cancers15133399","volume":"15","author":"J Krishnaraj","year":"2023","unstructured":"Krishnaraj J, Yamamoto T, Ohki R. p53-dependent cytoprotective mechanisms behind resistance to chemo-radiotherapeutic agents used in cancer treatment. Cancers. 2023;15(13):3399.","journal-title":"Cancers"},{"issue":"47","key":"496_CR69","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1038\/sj.onc.1208067","volume":"23","author":"K Adachi","year":"2004","unstructured":"Adachi K, Toyota M, Sasaki Y, Yamashita T, Ishida S, Ohe-Toyota M, et al. Identification of SCN3B as a novel p53-inducible proapoptotic gene. Oncogene. 2004;23(47):7791\u20138.","journal-title":"Oncogene"},{"key":"496_CR70","first-page":"36","volume":"321","author":"V Menon","year":"2014","unstructured":"Menon V, Povirk L. Involvement of p53 in the repair of DNA double strand breaks: multifaceted roles of p53 in homologous recombination repair (HRR) and non-homologous end joining (NHEJ). Mutant p53 MDM2 Cancer. 2014;321:36.","journal-title":"Mutant p53 MDM2 Cancer"},{"key":"496_CR71","doi-asserted-by":"crossref","first-page":"858756","DOI":"10.3389\/fonc.2022.858756","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Weng J. A pan-cancer bioinformatic analysis of RAD51 regarding the values for diagnosis, prognosis, and therapeutic prediction. Front Oncol. 2022;12:858756.","journal-title":"Front Oncol"},{"issue":"10","key":"496_CR72","doi-asserted-by":"crossref","first-page":"119317","DOI":"10.1016\/j.bbamcr.2022.119317","volume":"1869","author":"P Wolf","year":"2022","unstructured":"Wolf P, Schoeniger A, Edlich F. Pro-apoptotic complexes of BAX and BAK on the outer mitochondrial membrane. Biochim Et Biophys Acta (BBA)-Molecular Cell Res. 2022;1869(10):119317.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Cell Res"},{"issue":"10","key":"496_CR73","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/cells14100748","volume":"14","author":"A Fernandez","year":"2025","unstructured":"Fernandez A, Artola M, Leon S, Otegui N, Jimeno A, Serrano D, et al. Cancer vulnerabilities through targeting the ATR\/Chk1 and ATM\/Chk2 axes in the context of DNA damage. Cells. 2025;14(10):748.","journal-title":"Cells"},{"issue":"3","key":"496_CR74","first-page":"2591","volume":"16","author":"Y Dong","year":"2024","unstructured":"Dong Y, Wu X, Xu C, Hameed Y, Abdel-Maksoud MA, Almanaa TN, et al. Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures. Aging. 2024;16(3):2591.","journal-title":"Aging"},{"issue":"3","key":"496_CR75","doi-asserted-by":"crossref","first-page":"873","DOI":"10.62347\/NCPH5416","volume":"16","author":"L Huang","year":"2024","unstructured":"Huang L, Irshad S, Sultana U, Ali S, Jamil A, Zubair A, et al. Pan-cancer analysis of HS6ST2: associations with prognosis, tumor immunity, and drug resistance. Am J Translational Res. 2024;16(3):873.","journal-title":"Am J Translational Res"},{"issue":"7","key":"496_CR76","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.4103\/jcrt.jcrt_1902_21","volume":"19","author":"Y Hameed","year":"2023","unstructured":"Hameed Y. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses. J Cancer Res Ther. 2023;19(7):1852\u201364.","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"496_CR77","doi-asserted-by":"crossref","first-page":"940","DOI":"10.62347\/QNNE5428","volume":"16","author":"M Luo","year":"2024","unstructured":"Luo M, Rehman A, Haque S, Izhar S, Perveen F, Haris M, et al. Thorough examination of the potential biological implications of the cuproptosis-related gene LIPT2 in the prognosis and immunotherapy in pan-cancer. Am J Translational Res. 2024;16(3):940.","journal-title":"Am J Translational Res"},{"issue":"2","key":"496_CR78","doi-asserted-by":"crossref","first-page":"e230152","DOI":"10.1148\/rg.230152","volume":"44","author":"R Garc\u00eda-Figueiras","year":"2024","unstructured":"Garc\u00eda-Figueiras R, Baleato-Gonz\u00e1lez S, Luna A, Padhani AR, Vilanova JC, Carballo-Castro AM, et al. How imaging advances are defining the future of precision radiation therapy. Radiographics. 2024;44(2):e230152.","journal-title":"Radiographics"},{"issue":"1","key":"496_CR79","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41065-025-00369-9","volume":"162","author":"F Jiang","year":"2025","unstructured":"Jiang F, Ahmad S, Kanwal S, Hameed Y, Tang Q. Key wound healing genes as diagnostic biomarkers and therapeutic targets in uterine corpus endometrial carcinoma: an integrated in Silico and in vitro study. Hereditas. 2025;162(1):5.","journal-title":"Hereditas"},{"issue":"4","key":"496_CR80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/gtmb.2020.0249","volume":"25","author":"U Karamat","year":"2021","unstructured":"Karamat U, Ejaz S, Hameed Y. In silico-analysis of the multi-omics data identified the ataxia telangiectasia mutated gene as a potential biomarker of breast invasive carcinoma. Genetic Test Mol Biomarkers. 2021;25(4):263\u201375.","journal-title":"Genetic Test Mol Biomarkers"},{"issue":"2","key":"496_CR81","first-page":"244","volume":"4","author":"JA Nickoloff","year":"2021","unstructured":"Nickoloff JA, Taylor L, Sharma N, Kato TA. Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy. Cancer Drug Resist. 2021;4(2):244.","journal-title":"Cancer Drug Resist"},{"key":"496_CR82","doi-asserted-by":"crossref","first-page":"1337815","DOI":"10.3389\/fonc.2024.1337815","volume":"14","author":"D Rubini","year":"2024","unstructured":"Rubini D, Gagliardi F, Menditti VS, D\u2019Ambrosio L, Gallo P, D\u2019Onofrio I, et al. Genetic profiling in radiotherapy: a comprehensive review. Front Oncol. 2024;14:1337815.","journal-title":"Front Oncol"},{"issue":"1","key":"496_CR83","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1186\/s12967-023-04753-9","volume":"21","author":"Y Liu","year":"2023","unstructured":"Liu Y, Yang Y, Ni F, Tai G, Yu C, Jiang X, et al. Research on radiotherapy related genes and prognostic target identification of rectal cancer based on multi-omics. J Translational Med. 2023;21(1):856.","journal-title":"J Translational Med"},{"issue":"1","key":"496_CR84","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12967-023-04029-2","volume":"21","author":"P Zhao","year":"2023","unstructured":"Zhao P, Zhen H, Zhao H, Huang Y, Cao B. Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets. J Translational Med. 2023;21(1):176.","journal-title":"J Translational Med"},{"issue":"10","key":"496_CR85","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.7150\/thno.97768","volume":"14","author":"H Li","year":"2024","unstructured":"Li H, Gong Q, Luo K. Biomarker-driven molecular imaging probes in radiotherapy. Theranostics. 2024;14(10):4127.","journal-title":"Theranostics"},{"key":"496_CR86","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fonc.2013.00073","volume":"3","author":"S Braunstein","year":"2013","unstructured":"Braunstein S, Nakamura JL. Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk. Front Oncol. 2013;3:73.","journal-title":"Front Oncol"},{"issue":"12","key":"496_CR87","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ph15121475","volume":"15","author":"KN Venugopala","year":"2022","unstructured":"Venugopala KN. Targeting the DNA damage response machinery for lung cancer treatment. Pharmaceuticals. 2022;15(12):1475.","journal-title":"Pharmaceuticals"},{"key":"496_CR88","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.breast.2022.06.003","volume":"65","author":"R Graffeo","year":"2022","unstructured":"Graffeo R, Rana H, Conforti F, Bonanni B, Cardoso M, Paluch-Shimon S, et al. Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D. Breast. 2022;65:32\u201340.","journal-title":"Breast"},{"key":"496_CR89","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2022.09.007","volume":"176","author":"V Goel","year":"2022","unstructured":"Goel V, Sharma D, Sharma A, Mallick S. A systematic review exploring the role of modern radiation for the treatment of hereditary or Familial breast Cancer. Radiother Oncol. 2022;176:59\u201367.","journal-title":"Radiother Oncol"},{"issue":"30","key":"496_CR90","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.1200\/JCO.2005.00.471","volume":"23","author":"A Russo","year":"2005","unstructured":"Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol. 2005;23(30):7518\u201328.","journal-title":"J Clin Oncol"},{"issue":"9","key":"496_CR91","doi-asserted-by":"crossref","first-page":"e45388","DOI":"10.1371\/journal.pone.0045388","volume":"7","author":"MB Chen","year":"2012","unstructured":"Chen MB, Wu XY, Yu R, Li C, Wang LQ, Shen W, et al. P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer. PLoS ONE. 2012;7(9):e45388.","journal-title":"PLoS ONE"},{"key":"496_CR92","doi-asserted-by":"crossref","first-page":"165530","DOI":"10.1016\/j.scitotenv.2023.165530","volume":"898","author":"B \u00c1lvarez-Gonz\u00e1lez","year":"2023","unstructured":"\u00c1lvarez-Gonz\u00e1lez B, Porras-Quesada P, Arenas-Rodr\u00edguez V, Tamayo-G\u00f3mez A, V\u00e1zquez-Alonso F, Mart\u00ednez-Gonz\u00e1lez LJ, et al. Genetic variants of antioxidant and xenobiotic metabolizing enzymes and their association with prostate cancer: A meta-analysis and functional in Silico analysis. Sci Total Environ. 2023;898:165530.","journal-title":"Sci Total Environ"},{"issue":"2","key":"496_CR93","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2008.12.011","volume":"282","author":"L Khandrika","year":"2009","unstructured":"Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Cancer Lett. 2009;282(2):125\u201336.","journal-title":"Cancer Lett"},{"issue":"14","key":"496_CR94","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.3390\/math11143055","volume":"11","author":"M Lee","year":"2023","unstructured":"Lee M. Recent advances in generative adversarial networks for gene expression data: a comprehensive review. Mathematics. 2023;11(14):3055.","journal-title":"Mathematics"},{"issue":"8","key":"496_CR95","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1002\/cam4.1614","volume":"7","author":"X Zhu","year":"2018","unstructured":"Zhu X, Wang Y, Tan L, Fu X. The pivotal role of DNA methylation in the radio-sensitivity of tumor radiotherapy. Cancer Med. 2018;7(8):3812\u20139.","journal-title":"Cancer Med"},{"issue":"8","key":"496_CR96","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4161\/epi.25498","volume":"8","author":"DA Antwih","year":"2013","unstructured":"Antwih DA, Gabbara KM, Lancaster WD, Ruden DM, Zielske SP. Radiation-induced epigenetic DNA methylation modification of radiation-response pathways. Epigenetics. 2013;8(8):839\u201348.","journal-title":"Epigenetics"},{"issue":"7","key":"496_CR97","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/hmg\/ddp033","volume":"18","author":"JM Flanagan","year":"2009","unstructured":"Flanagan JM, Munoz-Alegre M, Henderson S, Tang T, Sun P, Johnson N, et al. Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. Hum Mol Genet. 2009;18(7):1332\u201342.","journal-title":"Hum Mol Genet"},{"key":"496_CR98","doi-asserted-by":"crossref","unstructured":"Goel M, Gupta V. Cutting-Edge technological developments in the diagnosis and treatment of malignant gastric neoplasm. Innovative advancements in biotechnology: technological advancements in biosciences. Springer; 2025. pp. 211\u201342.","DOI":"10.1007\/978-3-031-80189-1_16"},{"issue":"5","key":"496_CR99","doi-asserted-by":"crossref","first-page":"189139","DOI":"10.1016\/j.bbcan.2024.189139","volume":"1879","author":"X Wang","year":"2024","unstructured":"Wang X, Zhao G, Shao S, Yao Y. Helicobacter pylori triggers inflammation and oncogenic transformation by perturbing the immune microenvironment. Biochim Et Biophys Acta (BBA)-Reviews Cancer. 2024;1879(5):189139.","journal-title":"Biochim Et Biophys Acta (BBA)-Reviews Cancer"},{"issue":"9","key":"496_CR100","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1136\/gutjnl-2019-318640","volume":"69","author":"L Costa","year":"2020","unstructured":"Costa L, Corre S, Michel V, Le Luel K, Fernandes J, Ziveri J, et al. USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis. Gut. 2020;69(9):1582\u201391.","journal-title":"Gut"},{"issue":"2","key":"496_CR101","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajpath.2017.10.005","volume":"188","author":"JC Santos","year":"2018","unstructured":"Santos JC, Gambeloni RZ, Roque AT, Oeck S, Ribeiro ML. Epigenetic mechanisms of ATM activation after helicobacter pylori infection. Am J Pathol. 2018;188(2):329\u201335.","journal-title":"Am J Pathol"},{"issue":"1","key":"496_CR102","doi-asserted-by":"crossref","first-page":"2463581","DOI":"10.1080\/19490976.2025.2463581","volume":"17","author":"X Xu","year":"2025","unstructured":"Xu X, Fei X, Wang H, Wu X, Zhan Y, Li X, et al. Helicobacter pylori infection induces DNA double-strand breaks through the ACVR1\/IRF3\/POLD1 signaling axis to drive gastric tumorigenesis. Gut Microbes. 2025;17(1):2463581.","journal-title":"Gut Microbes"},{"issue":"5","key":"496_CR103","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3390\/molecules22050744","volume":"22","author":"S Zhang","year":"2017","unstructured":"Zhang S, Huang J, Xie X, He Y, Mo F, Luo Z. Quercetin from Polygonum capitatum protects against gastric inflammation and apoptosis associated with Helicobacter pylori infection by affecting the levels of p38MAPK, BCL-2 and BAX. Molecules. 2017;22(5):744.","journal-title":"Molecules"},{"issue":"1","key":"496_CR104","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s43042-025-00689-5","volume":"26","author":"S Absalan","year":"2025","unstructured":"Absalan S, Vaziri H. The role of non-coding RNAs (ncRNAs) and their potential connection with cancer. Egypt J Med Hum Genet. 2025;26(1):55.","journal-title":"Egypt J Med Hum Genet"},{"key":"496_CR105","doi-asserted-by":"crossref","unstructured":"Li M-M, Shi M-J, Feng C-C, Yu Z-Y, Bai X-F. LncRNA KCNQ1OT1 promotes NLRP3 inflammasome activation in Parkinson\u2019s disease by regulating pri-miR-186\/mature miR-186\/NLRP3 axis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2024;1870(8):167454.","DOI":"10.1016\/j.bbadis.2024.167454"},{"issue":"5","key":"496_CR106","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1166\/jbn.2024.3838","volume":"20","author":"J Liu","year":"2024","unstructured":"Liu J, Zhang Y, Wu J, Liu X, Li L, Zhang J. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p\/PLOD1\/Akt\/mTOR pathway. J Biomed Nanotechnol. 2024;20(5):909\u201319.","journal-title":"J Biomed Nanotechnol"},{"key":"496_CR107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2024.05.002","volume":"286","author":"D Liu","year":"2024","unstructured":"Liu D, Shen M, Liu Z, Chen D, Pan Y, Zhang L, et al. SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1. Cancer Genet. 2024;286:1\u201310.","journal-title":"Cancer Genet"},{"issue":"1","key":"496_CR108","first-page":"vdab015","volume":"3","author":"NK Majd","year":"2021","unstructured":"Majd NK, Yap TA, Koul D, Balasubramaniyan V, Li X, Khan S, et al. The promise of DNA damage response inhibitors for the treatment of glioblastoma. Neurooncol Adv. 2021;3(1):vdab015.","journal-title":"Neurooncol Adv"}],"updated-by":[{"DOI":"10.1186\/s41065-026-00753-z","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000}}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00496-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00496-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00496-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:44:21Z","timestamp":1791668661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-025-00496-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00496-3","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s41065-026-00753-z","URL":"https:\/\/doi.org\/10.1186\/s41065-026-00753-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"125"}}